Eremid is a high complexity genomics CRO, focusing on science that influences human health and agbiotech. The company offers specialist expertise in nucleic acid extraction, long and short read sequencing technologies, and data analysis, delivering high quality research-enhancing data through customized, collaborative projects. Eremid has invested in world-class scientific staff, and cutting-edge genomic instrumentation and automation to create an offering that meets the increasing demands for higher data quality, reliability, and accuracy in genomics research.